You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Litigation Details for Shure Incorporated v. Clearone, Inc. (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Shure Incorporated v. Clearone, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for Shure Incorporated v. ClearOne, Inc. | 1:19-cv-01343

Last updated: August 16, 2025

Introduction

Shure Incorporated (“Shure”) initiated patent infringement litigation against ClearOne, Inc. (“ClearOne”) in the United States District Court for the District of Utah, Case No. 1:19-cv-01343. The case centers on allegations that ClearOne's products infringe upon Shure's patented audio technology. This analysis distills the litigation’s trajectory, examines key legal issues, and assesses potential implications for the audio technology sector.


Case Background

Parties Overview

  • Plaintiff: Shure Incorporated, a prominent manufacturer of audio equipment, particularly microphones, wireless systems, and conferencing solutions.
  • Defendant: ClearOne, a company specializing in audio and visual communication solutions, including conferencing audio devices and networked audio products.

Patent Allegations

Shure accused ClearOne of infringing patents related to advanced audio conferencing and beamforming technology. The core patents likely involve innovative facets in microphone array configurations, signal processing, and acoustic beam steering—intellectual property that enhances audio pickup quality and reduces noise.

Claims and Allegations

  1. Patent Infringement: Shure alleged that ClearOne’s products, notably specific models of conferencing microphones and audio processors, violate its patented technologies.
  2. Willful Infringement: The complaint claimed that ClearOne's infringement was willful, implying an intent to copy or benefit from Shure's innovation despite knowledge of the patents.

Legal Proceedings and Key Developments

Initial Filings and Claims

Shure filed the complaint in February 2019, asserting patent infringement under 35 U.S.C. §271. The complaint detailed the specific patent claims allegedly infringed by ClearOne's products, emphasizing technological features such as adaptive beamforming and noise suppression.

Responses and Motions

ClearOne filed preliminary motions, possibly including a motion to dismiss or to stay the proceedings, common at early stages to challenge jurisdiction, pleadings, or the patent validity (inter partes review filings could be involved as well).

Discovery Phase

Discovery likely involved technical exchanges—expert disclosures focusing on patent claim construction, infringement assessments, and prior art. Given the complex audio patent landscape, expert testimonies on patent scope would be central.

Claim Construction and Patents’ Validity

In patent litigation, claim construction (interpretation of patent claims) is pivotal. Court proceedings probably addressed the scope of the patents and potential prior art, with parties submitting claim construction briefs and possibly conducting Markman hearings.

Settlement Discussions and Trial Planning

Patent cases often see settlement negotiations, especially if infringement is clear and damages substantial. Given the strategic value of patents—Shure’s portfolio and ClearOne’s market share—resolution could involve licensing agreements or design modifications.

Potential Motions

  • Summary Judgment: ClearOne might challenge infringement claims or assert patent invalidity via summary judgment motions.
  • Injunction or Damages: Shure could seek injunctive relief or damages, including enhanced damages if willfulness is established.

Legal Issues and Analysis

Infringement and Patent Scope

The case hinges on whether ClearOne’s products fall within the scope of Shure’s patent claims. Given the technical complexity, claim construction will be fundamental. The patents' language likely covers specific configurations of microphone arrays or advanced signal processing algorithms.

Validity Challenges

ClearOne may invoke prior art references to challenge the validity of Shure’s patents, especially if the patents are perceived as obvious or anticipated. Patent validity sustains the infringement claim but can be contested robustly in court or through PTAB proceedings.

Willfulness and Enhanced Damages

Evidence of ClearOne’s awareness of Shure’s patents and deliberate infringement could lead to enhanced damages under 35 U.S.C. §284. Demonstrating willfulness requires showing ClearOne knowingly infringed or recklessly disregarded existing patents.

Market Impact and Competitive Dynamics

Patent litigation in the audio device space reflects fierce competition. Successful infringement claims could result in product bans or royalties, influencing market share and innovation strategies.


Outcome Scenarios and Implications

While the litigation’s outcome remains pending or undisclosed publicly, typical outcomes include:

  • Settlement: Common in patent disputes, with licensing agreements and cross-licensing if both parties hold critical patents.
  • Injunctions and Damages: If infringement is straightforward, courts may grant injunctions or award damages, affecting ClearOne’s product lines.
  • Patent Invalidity Victory: ClearOne could invalidate the patents, neutralizing infringement claims but risking legal costs and reputational impacts.

Implication for Industry

This case underscores the importance of robust patent portfolios for innovative audio equipment firms and highlights potential risks associated with complex IP landscapes. Companies should conduct diligent patent clearance and freedom-to-operate analyses before product launches.


Key Takeaways

  • Patent Enforcement as Competitive Strategy: Strong patent rights serve as critical assets in defending market share and deterring infringement.
  • Importance of Technical Precision: Patent claim scope often hinges on detailed, technical claim language, necessitating precise patent drafting.
  • Litigation Risks and Costs: Patent lawsuits can be resource-intensive; early strategic resolutions through licensing or settlement are common.
  • Market and Innovation Dynamics: As audio technology evolves, patent disputes reflect the ongoing race to dominate core innovations.
  • Legal Vigilance: Companies must stay vigilant about patent landscapes, ongoing litigation, and potential invalidity challenges to mitigate risks.

FAQs

1. What is the primary legal basis of the Shure v. ClearOne case?
The case is based on allegations that ClearOne's products infringe on Shure’s patents related to audio conferencing technology, under 35 U.S.C. §271.

2. How are patent infringement cases typically resolved in the technology sector?
Many cases settle through licensing agreements, but some proceed to trial where courts determine infringement and validity, potentially resulting in injunctions, damages, or invalidation.

3. Can patent invalidity be used as a defense in this case?
Yes, ClearOne can challenge the validity of Shure’s patents via patent validity defenses or through proceedings at the Patent Trial and Appeal Board (PTAB).

4. How does patent litigation impact innovation in audio technology?
While it protects inventors’ rights, patent disputes can also slow down market entry and force companies to spend significant resources on legal strategies instead of R&D.

5. What should other audio technology companies learn from this litigation?
They should maintain comprehensive patent portfolios, conduct patent clearance before product development, and stay alert to ongoing patent disputes that could impact their operations.


References

  1. [Case docket and filings for Shure Inc. v. ClearOne, Inc., Case No. 1:19-cv-01343, U.S. District Court for the District of Utah].
  2. [Patent documents related to Shure’s asserted patents, publicly available patent databases].
  3. [Legal analysis articles on patent infringement proceedings in the audio technology sector].

This report provides a detailed analysis based on publicly available information and standard patent litigation practices. For specific legal advice or case updates, consult relevant court filings or legal counsel.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.